Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
MarketScreener,
MENLO PARK - Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing…